Katten is a proud sponsor of the IPMI's Healthcare Law & Compliance Institute, featuring presentations by three of Katten's Health Care attorneys.
Laura Keidan Martin, partner, will serve as a panelist during the "Critical Insights, Updates and Considerations in the Healthcare Law Landscape" session at 10:00 a.m. on Monday, October 4. In addition to the massive disruptions caused by the COVID-19 pandemic, panelists will discuss key questions on the minds of hospital and health system general counsels and chief legal officers, including mergers, acquisitions and dispositions, joint ventures and syndications, contracting, regulatory and operational matters or compliance and investigations.
Associate Ramana Rameswaran will present the "Think Tank: Returning to Normal: Addressing Compliance After COVID-19 Changes and Funding" session at 11:30 a.m. The presentation will examine how compliance will need to be readdressed as the Public Health Emergency declared for the pandemic winds down. Ramana will cover:
- the status of COVID-19-related fraud and abuse, telehealth, and privacy waivers/enforcement discretion;
- strategies to address or to reverse initiatives introduced during the Public Health Emergency; and
- COVID-19 Health Care Funding Programs (e.g., Provider Relief Funds and Medicare Accelerated and Advance Payment programs).
At 2:00 p.m., Laura will co-present the "Avoiding Antitrust and Regulatory Pitfalls in Strategic Transactions" session with associate Rachel Adams. The presentation will explore Biden administration antitrust scrutiny of health care transactions and False Claim Act (FCA) cases. Topics include:
- Antitrust Agency enforcement developments;
- outcomes in recent health care antitrust cases and how they impact defense strategies;
- antitrust best practices and strategies to minimize risk;
- how the new Stark Law and AKS rules impact transaction structures and diligence; and
- tactics for identifying and addressing compliance issues during due diligence.